ライフサイエンスコーパス: comorbidity

1 years and no significant ocular or systemic comorbidity.

2 re associated with higher risks of AD and MD comorbidity.

3 % [1308 of 3074], P < .001) and have greater comorbidity.

4 r recurrence were older age, female sex, and comorbidity.

5 epsis patients without any documented immune comorbidity.

6 ysis stratified by the degree of preexisting comorbidity.

7 for all 13 serotypes, regardless of age and comorbidity.

8 ssive articular damage, functional loss, and comorbidity.

9 ards model adjusting for age, sex, race, and comorbidity.

10 n rates correlated with patient symptoms and comorbidity.

11 ptibility contributes modestly to MDD and AD comorbidity.

12 were reviewed for sociodemographic data and comorbidities.

13 e, better baseline renal function, and fewer comorbidities.

14 IV, and examine dependency between causes of comorbidities.

15 n present alone or in combination with other comorbidities.

16 patient characteristics such as age, sex, or comorbidities.

17 cal records and patient reports in assessing comorbidities.

18 ays drive articular inflammation and related comorbidities.

19 ecords were abstracted to identify potential comorbidities.

20 tial strategy against obesity and associated comorbidities.

21 died (4% [95% CI, 1%-8%]), including 5 with comorbidities.

22 increase the risk of obesity and associated comorbidities.

23 o drive the eventual development of multiple comorbidities.

24 rgan failure in patients without substantial comorbidities.

25 are initially seen with increasingly complex comorbidities.

26 , and (3) patient-related factors, including comorbidities.

27 , urban and rural residence, and preexisting comorbidities.

28 nces in efficacy were seen by sex or by most comorbidities.

29 n, 3.0 versus 4.0 years; P<0.0001) and fewer comorbidities.

30 rtion of children with RSV-related death had comorbidities.

31 screening up to age 85, depending on age and comorbidities.

32 substantial after adjusting for psychiatric comorbidities.

33 analyses by surgical risk, demographics, and comorbidities.

34 ome and multi-organ failure in patients with comorbidities.

35 and competing risks analysis, adjusting for comorbidities.

36 had poor prognostic factors, or had serious comorbidities.

37 ce, gender, severity of illness, and chronic comorbidities.

38 ation and gastrointestinal issues are common comorbidities.

39 ted factors, such as age and the presence of comorbidities.

40 nd is often associated with neuropsychiatric comorbidities.

41 d among male and younger patients with fewer comorbidities.

42 ased on the patient's performance status and comorbidities.

43 1.8%, 27.2%, and 54.0%) were the most common comorbidities.

44 psychiatric disorders among the most common comorbidity (10% of all SPASTpatients).

45 0.79 years, 95% CI 0.37-1.20; mean number of comorbidities 3.4 [SD 1.9] vs 5.4 [2.5]; adjusted differ

46 est population attributable fractions of the comorbidities (3.4%).

47 and other chronic pain conditions, and these comorbidities add to the amount of disability in both se

48 The history should include a review of comorbidities, adherence to medications, previous episod

49 fection ratios (SIR) to assess the impact of comorbidity adjustment on public reporting.

50 ng of select comorbidities for the dependent comorbidity adjustments.

51 sease onset comprises synovitis and systemic comorbidities affecting the vasculature, metabolism, and

52 This large observational study suggests that comorbidity affects other cause-mortality but not PCa-sp

53 ers (demographics, clinical characteristics, comorbidities, albumin, and residual kidney function).

54 ients (31.6%) that fulfilled criteria of low comorbidity (American Society of Anesthesiologists score

55 rlap exists in the clinical presentation and comorbidities among patients with Middle East respirator

56 Estimates were adjusted for the presence of comorbidities and are reported using inflation-adjusted

57 all-cause mortality, accounting for patient comorbidities and case-mix.

58 r adverse events because of multiple medical comorbidities and drug-drug interactions in case of poly

59 AN) and obesity are complicated by affective comorbidities and hypothalamic-pituitary-gonadal dysregu

60 ent option for patients who have significant comorbidities and limited life expectancy.

61 g elderly population, the high prevalence of comorbidities and medications for chronic diseases may o

62 xamine the application of syndemic theory to comorbidities and multimorbidities in low-income and mid

63 n of serostatus in a subanalysis, as well as comorbidities and other factors that affect cognition.

64 ly observed in different age strata, various comorbidities and patients without use of class I/III an

65 ays), quality of life (CU-Q2oL and/or DLQI), comorbidities and possible causes of CSU, and autologous

66 loss over 5 years, alongside improvements in comorbidities and risk factors.

67 sion was used to assess associations between comorbidities and severe malaria.

68 rolled for matching factors and adjusted for comorbidities and socioeconomic status.

69 d in African Americans persons whose cardiac comorbidities and structural abnormalities differ.

70 proportion of patients with TBI-as preinjury comorbidities and their therapies demand tailored manage

71 Comorbidities and work-related relative value units (cat

72 ns of coronary atherothrombosis, in light of comorbidities and/or interventional procedures.

73 al profile included older patients with more comorbidity and a rise in enterococci and coagulase-nega

74 After controlling for comorbidity and acuity of illness, radiocontrast adminis

75 a logistic regression model, controlling for comorbidity and acuity of illness, to estimate the risk

76 h values are a marker for poor nutrition and comorbidity and are often highly variable from month to

77 study, we sought to clarify the patterns of comorbidity and familial clustering of a broad range of

78 wel disease is associated with psychological comorbidity and impaired quality of life.

79 me-linked immunosorbent assay, and events of comorbidity and mortality were ascertained by registry l

80 rdiac disease in aging populations with high comorbidity and mortality.

81 sease severity (dyspnea, QoL, exacerbations, comorbidities) and prognosis (mortality) are not differe

82 s with PHS risks (but relatively few medical comorbidities) and tested negative for HCV were less fre

83 frail patients, 19.4% of those with multiple comorbidities, and 17.7% of otherwise healthy patients)

84 n after adjustment for demographics, medical comorbidities, and active depression.

85 multiple confounders including demographics, comorbidities, and admission characteristics, incorporat

86 uch as reduced treatment tolerance, multiple comorbidities, and altered pharmacokinetics and pharmaco

87 well matched by age, body mass index, major comorbidities, and cardiac function.

88 healthy animals which lack the risk factors, comorbidities, and comedications which are characteristi

89 d by CLI presentation, patient demographics, comorbidities, and in-hospital complications, but not by

90 individual basis, considering side effects, comorbidities, and levels of peripheral and centralized

91 care, currently driving, a greater number of comorbidities, and lower vision-specific quality-of-life

92 ed risk of developing neurological cognitive comorbidities, and may extend to multiple neuropsychiatr

93 of diabetes mellitus, other obesity-related comorbidities, and mortality.

94 cted to model the interdependencies of these comorbidities, and network-clustering analysis was appli

95 rehensive evaluation for medical conditions, comorbidities, and psychosocial or behavioral patterns t

96 es in patient characteristics, demographics, comorbidities, and reason for admission between locum te

97 d participants were controlled for age, sex, comorbidities, and secular trends.

98 y accordingly, based on patient preferences, comorbidities, and tolerability might be possible.

99 x, race, stage, surgery type, margin status, comorbidities, and use of chemotherapy.

100 ge, male sex, university hospital admission, comorbidity, and low Simplified Acute Physiology Score 3

101 ine eGFR, urine albumin-to-creatinine ratio, comorbidity, and measures of mineral metabolism.

102 ded obesity, obstructive sleep apnea, higher comorbidity, and use of prescription opioids and/or benz

103 y debilitating neuropsychiatric and systemic comorbidities; and carry a grave risk of mortality.

104 ed 1-year survival of patients with AML, and comorbidities are best captured by an augmented HCT-CI.

105 In this review, eight major asthma-related comorbidities are discussed: rhinitis, chronic rhinosinu

106 Traditional cardiovascular comorbidities are more prevalent in obese individuals an

107 various BBS phenotypes and their associated comorbidities are reviewed herein.

108 -term effects on HIV disease progression and comorbidities are unknown.

109 tions addressing arthritis and mental health comorbidities are warranted to tackle this considerable

110 metabolic profile, lower prevalence rates of comorbidities (arterial hypertension, diabetes mellitus,

111 erectomy successfully provides recovery from comorbidities as a lifesaving procedure and does not com

112 operative/intraoperative variables (eg, age, comorbidities, ASA, wound classification), procedure typ

113 We then determined risk factors and medical comorbidities associated with behavioural and emotional

114 odevelopmental impairment is the most common comorbidity associated with complex congenital heart dis

115 ociations can arise indirectly through other comorbidity associations and they increase exponentially

116 cipants are followed for health outcomes and comorbidities at 12, 24, 48, 72, and 96 months after bas

117 wo pediatric psychiatric disorders with high comorbidity: autism spectrum disorder (ASD) and Tourette

118 Comorbidity-based risk adjustment should be strongly con

119 outcomes, adjusting for age, sex, education, comorbidities, baseline disability, baseline cognition,

120 ta-analysis to identify whether the observed comorbidity between ADHD and BPD could be due to shared

121 n strength, which could explain the observed comorbidity between diseases caused by the same genetic

122 These results suggest that comorbidity between schizophrenia and substance use diso

123 Biopsy or intervention, comorbidity, black race, low income, public insurance, a

124 greater than that seen for groups with less comorbidity burden (0 and 1).

125 In the groups with greatest comorbidity burden (2 and >/=3), the absolute risk reduc

126 AIAN had a significantly higher comorbidity burden compared with NHW (P < 0.05).

127 death or nonfatal HF events with increasing comorbidity burden regardless of treatment group (p < 0.

128 alth at patient HF diagnosis was assessed by comorbidity burden, self-reported difficulty with activi

129 (>/=60 and <60 years of age) and presence of comorbidities but worsened among patients <60 years of a

130 and increased hazard rates for both non-AIDS comorbidities (cardiovascular disease, chronic kidney di

131 e demographics, recommended interval length, comorbidities, clinical presentation, location at second

132 ble to the PiB- individuals on demographics, comorbidities, cognition, hippocampal volume, and small-

133 Psychiatric comorbidity complicates clinical care and confounds effo

134 BBS clinical phenotypes and consequent oral comorbidities confound oral health management.

135 r potential sociodemographic, maternity, and comorbidity confounders.

136 ars of age, 13% were non-white, and the mean comorbidity count was 2.38 (standard deviation 1.22).

137 survival analysis adjusted for age, sex, and comorbidity, cystatin C was near-linearly associated wit

138 ed approach to discern disease subtypes from comorbidity data recorded in longitudinal data sets.

139 anaphylaxis and allergic or hypersensitivity comorbidities description.

140 nomically deprived individuals also had more comorbidities, despite their younger age.

141 l Classification of Diseases, Tenth Revision comorbidity diagnoses and demographic and socioeconomic

142 ropensity score matching (based on sex, age, comorbidity, disease severity, and previous reinterventi

143 tectomy or radical radiotherapy), increasing comorbidity does not seem to significantly affect the ri

144 ate odds ratios (ORs) that were adjusted for comorbidity, education level, and income level.

145 ection, without other somatic or psychiatric comorbidity explaining the fatigue.

146 Atopic dermatitis comorbidities extend well beyond the march to allergic c

147 tes was assessed to the sequencing of select comorbidities for the dependent comorbidity adjustments.

148 ta on dialysis modality, insurance type, and comorbidities from the United States Renal Data System.

149 We used propensity matching to control for comorbidity, functional status, postoperative complicati

150 t study to date, we compare 22q11DS to ND in comorbidities, functioning, cognition, and psychosis fea

151 stic Scoring System (IPSS-R) and presence of comorbidity graded according to the HCT Comorbidity Inde

152 tical significance between different age and comorbidity groups, and thus these results are explorato

153 nd in the degree of reverse remodeling among comorbidity groups.

154 for age, epidemic period, MERS patients with comorbidity had around 4 times the risk for fatal infect

155 ding relationships between diseases, such as comorbidities, has important socio-economic implications

156 These comorbidities have been proposed as "treatable traits" i

157 confidence interval [CI], 0.97-0.99), fewer comorbidities (HR, 0.89; 95% CI, 0.84-0.95), being marri

158 inal HCT-CI with 3 independently significant comorbidities, hypoalbuminemia, thrombocytopenia, and hi

159 storical claims data increased the number of comorbidities identified, but did not enhance model perf

160 burden and determinants of complications and comorbidities in contemporary youth-onset diabetes are u

161 ning a pragmatic clinical approach to assess comorbidities in difficult asthma.

162 accepting recipients who are older with more comorbidities in recent years, the 3-year cumulative inc

163 , care engagement, and optimum management of comorbidities in reducing mortality in people with HIV.

164 or an ageing population living with multiple comorbidities in the face of a stagnant level of the per

165 emotional problems in preschool children and comorbidities in the Kilifi Health and Demographic Surve

166 e findings portend increases in many chronic comorbidities in which alcohol use has a substantial rol

167 374 (12%) admissions, and recorded only as a comorbidity in 86 874 (19%) admissions.

168 We sought to investigate if comorbidity, in terms of chronic diseases and obesity, i

169 Main comorbidities included coronary artery disease (51.5%),

170 Comorbidities included hypertension (77%), diabetes mell

171 ents with vascular anomalies and significant comorbidities, including one case of blood group incompa

172 stly poorer even after adjusting for medical comorbidity, including increased reliance on gait aids (

173 Methods Patients age 18 to 65 years with HCT comorbidity index </= 4 and < 5% marrow myeloblasts pre-

174 Data were stratified by Charlson comorbidity index (0, 1, 2, or >/= 3).

175 ated and compared with age-adjusted Charlson Comorbidity Index (CCI) by using the Harrell c statistic

176 e of comorbidity graded according to the HCT Comorbidity Index (HCT-CI) were recognized as relevant c

177 stic and AUC estimates compared with the AML comorbidity index for prediction of 1-year mortality.

178 first physical therapy evaluation, Charlson Comorbidity Index score, mean days of physical therapy t

179 ugh scores ( P < .001), and higher Cirrhosis Comorbidity Index scores ( P = .01).

180 The median Charlson comorbidity index was 4.

181 etween sex, social deprivation, and Charlson Comorbidity Index with incident epilepsy, accounting for

182 ck/Hispanic race, prior amputation, Charlson comorbidity index, and need for home health care or reha

183 graphics, AAL history, age-adjusted Charlson comorbidity index, infection history, and antibiotic usa

184 nt effect according to age, gender, Charlson comorbidity index, pathologic stage (pT3/T4N0, pT3/T4Nx

185 age, sex, race/ethnicity, modified Charlson comorbidity index, smoking, and alcohol use.

186 The patients' age, comorbidities, indication, and extent of surgery, and al

187 IVIG subjects were younger with lower comorbidity indices, but higher illness severity.

188 In this cohort study, comorbidities influenced 1-year survival of patients wit

189 no differences in age, race/ethnicity, sex, comorbidities, insurance status, left ventricular functi

190 ptor status for each variable (demographics, comorbidity, insurance, tumor characteristics, and treat

191 ntibiotic susceptibility, presence of fever, comorbidities (intravenous central lines, urinary cathet

192 Improvement of comorbidities is similar except for gastro-esophageal re

193 abis dependence-without the confounds of any comorbidity-is associated with a deficit in striatal dop

194 other cancers, general preventive care, and comorbidity management.

195 The sparse comorbidity map confirmed that depressed patients freque

196 patients with diabetes to determine how this comorbidity may affect poststroke cortical plasticity an

197 E, performed by experts in patients with low comorbidity, may serve as a benchmark procedure for esop

198 ion among a diverse population regardless of comorbidity measure used.

199 of 157 men with minimal comorbidities or no comorbidity (median follow-up, 16.49 months).

200 graphic characteristics, clinical variables, comorbidities, medications, and biomarkers into Cox prop

201 COPD is associated with several comorbidities (multimorbidity), such as cardiovascular a

202 in the German COPD and Systemic Consequences-Comorbidities Network cohort study.

203 A Bayesian comorbidity network was constructed to model the interde

204 emographic, dual Medicare/Medicaid coverage, comorbidities, not filling high-intensity statin prescri

205 We developed a neuropathological comorbidity (NPC) score and compared it to CDR, IQCODE,

206 for the pathophysiology of gastrointestinal comorbidities of ASD.

207 rks, and respiratory problems were important comorbidities of behavioural and emotional problems.

208 nts with HF with genetic predispositions and comorbidities of chronic diseases exhibit poor prolifera

209 .005), but not with other possible causes or comorbidities of CSU.

210 A modest increase in comorbidity of ALS and schizophrenia is expected given t

211 We identified comorbidity of anxiety and depression in landmine or UXO

212 ons at two loci previously implicated in the comorbidity of asthma plus hay fever, and confirmed nine

213 n is increasingly recognized as an important comorbidity of HIV-infected patients, however, the exact

214 Hypercholesterolemia, a common comorbidity of obesity, has been shown to increase cance

215 rovide an effective therapeutic approach for comorbidity of smoking and these conditions.

216 ompare and explore infectome, diseasome, and comorbidity of ZIKV infections.

217 siologic perturbations that resemble medical comorbidities often seen in ASD and other neuropsychiatr

218 patients with clinical ASCVD with or without comorbidities on statin therapy for secondary prevention

219 fect of relevant factors, notably underlying comorbidities, on fatal outcome of Middle East respirato

220 esults There were no baseline differences in comorbidities or cytokines between survivors and the con

221 number of elderly patients with significant comorbidities or high operative risk.

222 ooks at the subgroup of 157 men with minimal comorbidities or no comorbidity (median follow-up, 16.49

223 In those with significant comorbidities or those not undergoing surgery, competing

224 Exclusion criteria included any comorbidity or laboratory abnormality that might confoun

225 s to quantify the proportion with individual comorbidities over the period, by payer.

226 78]; p < 0.001), clinical presentations and comorbidities overlapped substantially.

227 ered significantly, with a greater number of comorbidities (P<0.0001), CHDs with univentricular outco

228 Network analysis of comorbidity patterns captured most of the major PH subty

229 Comorbidity patterns have become a major source of infor

230 Application of network science to model comorbidity patterns recorded in longitudinal data sets

231 urther when comorbidity was expressed as the COmorbidity Point Score 2 (C-statistic, 0.737; 95% CI, 0

232 tal, and adjusting for patient demographics, comorbidities, presence of cirrhosis, and annual surgica

233 Patient demographics, comorbidities, presenting symptoms and vision, vitreoret

234 We examined changes in patient demographics, comorbidities, procedure use, and risk-adjusted in-hospi

235 i.e., age, gender, dementia stage, function, comorbidity, psychoactive medication use) and nesting ef

236 0-, and 365-d) after adjusting for number of comorbidities, psychological conditions, and demographic

237 of baseline patient characteristics, medical comorbidities, quality of center performing the surgery,

238 Both groups were compared for weight loss, comorbidities, quality of life, and complications.

239 renal disease, hemoglobin, albumin, selected comorbidities, race and type of insurance as well as don

240 Classes were characterized by comorbidity rates and proportion of parents included.

241 omorbid oppositional defiant disorder (ODD) (comorbidity rates up to 60%) on these neuroanatomical di

242 stics (tumor stage, grade, nodal status, and comorbidity) rather than differences in treatment.

243 virus (HIV)-infected patients with specific comorbidities receiving healthcare coverage from commerc

244 l described associations such as the inverse comorbidity relationship between Alzheimer's disease and

245 ative complications and 1-year self-reported comorbidity remission.

246 This high comorbidity requires adequate treatment but the underlyi

247 of both cardiovascular and noncardiovascular comorbidities rose: heart failure (13.9%-34.4%), pulmona

248 A higher comorbidity score was independently associated with incr

249 odemographic factors, tumor characteristics, comorbidity score, and other medications to estimate HRs

250 age, race, sex, cancer acuity (high vs low), comorbidity score, and preenrollment characteristics (co

251 Cooperative Oncology Group status, Charlson comorbidity score, treatment date, age, carcinoma in sit

252 In multivariable analysis, higher comorbidity scores and history of smoking were associate

253 tient, disease characteristics, and Charlson comorbidity scores, all-cause mortality and cancer-speci

254 To develop the first set of guidelines for comorbidity screening for patients with pediatric psoria

255 ioural and emotional problems and associated comorbidities should be identified and addressed in youn

256 evaluation of symptom control, risk factors, comorbidities, side-effects, and patient satisfaction by

257 ntation, controlling for year, demographics, comorbidities, socioeconomic factors, and Organ Procurem

258 Comorbidities, specifically obesity and diabetes, are pr

259 rates after taking into account the age and comorbidity status of patients.

260 nce of concomitant heart disease and medical comorbidities, stress testing represents a reasonable st

261 ation which tends to be older and plagued by comorbidities such as diabetes mellitus and hypertension

262 text-mining and molecular-level measures for comorbidities such as genetic overlap and the interactom

263 weight loss in obese individuals and reduces comorbidities such as type 2 diabetes.

264 ity of ocular pain correlates with nonocular comorbidities such as use of antidepressant medications

265 Furthermore, comorbidities such as valvular heart disease and renal f

266 along the visual axis and significant visual comorbidities, such as angle closure glaucoma, cystic ma

267 rdiomyopathies often occur in the absence of comorbidities, such as atherosclerosis, hypertension, re

268 Antiretroviral therapy; HIV-associated comorbidities, such as dyslipidemia, drug abuse, and opp

269 Six children had autoimmune comorbidity, such as thyroiditis and type 1 diabetes.

270 ity of illness, and have more cardiovascular comorbidities than ever before.

271 Patients with cellulitis had more chronic comorbidities than patients with necrotizing fasciitis (

272 djusting for copayments, poverty status, and comorbidities, the association was no longer significant

273 After adjusting for age, sex, and comorbidities, the risk of death or major cardiovascular

274 After adjusting for psychiatric comorbidities, the risk was reduced but remained substan

275 After adjustment for patient age, sex, and comorbidity, there were no independent associations of s

276 A and sex, age, body mass index, and medical comorbidities through multivariable analysis.

277 ere individually matched by demographics and comorbidities to a Medicare enrollee without cancer, and

278 d has allowed elderly patients or those with comorbidity to receive an HSCT.

279 proportions of different types of diabetes, comorbidities, treatment (the use of oral glucose-loweri

280 he contribution of differences in insurance, comorbidities, tumor characteristics, and treatment rece

281 a were collected, including body mass index, comorbidities, tumor histologic characteristics and grad

282 ds provided information on sociodemographic, comorbidity, tumor, clinical, and treatment characterist

283 This outcome analysis of patients with low comorbidity undergoing ttMIE may serve as a reference to

284 Demographic, laboratory, and comorbidity variables measured prior to discharge.

285 trade-offs between graft health and medical comorbidities was fundamental.

286 escence, the prevalence of complications and comorbidities was higher among those with type 2 diabete

287 Model discrimination improved further when comorbidity was expressed as the COmorbidity Point Score

288 Most common comorbidities were allergic rhinitis (62.4%), gastroesop

289 y tract anomalies, premature birth, or major comorbidities were excluded from participation.

290 A total of 186 comorbidities were found to be significantly associated

291 Poor lung function and comorbidities were predictive of poor technique, whereas

292 The most frequent comorbidities were rhinitis (84.0%), sinusitis (47.8%),

293 Ocular comorbidities were slightly more prevalent in DSBCS pati

294 c ethnicity, bonded release, and psychiatric comorbidity were also associated with LTC within 30 days

295 57 to -0.44) had a higher level of AD and MD comorbidity, while larger intracranial (beta = 1.07; 95%

296 nd prevalences of these diseases and linking comorbidities with autoantibody reactivities and clinica

297 Targeting comorbidities with interventions alongside specific AML

298 Comorbidities with the largest relative difference in ad

299 lder patients and those with a history of CV comorbidities within 1.5 years of initiating androgen-de

300 aphic information and baseline self-reported comorbidities, yielded hazard ratios of 0.88 (95% CI, 0.